Literature DB >> 19755063

Matrix-Induced Autologous Chondrocyte Implantation (MACI) grafting for osteochondral lesions of the talus.

Timothy E Schneider1, Sriram Karaikudi.   

Abstract

BACKGROUND: Articular cartilage is limited in its ability to repair itself. Matrix-induced Autologous Chondrocyte Implantation (MACI) is an established treatment method for such articular cartilage defects in the knee. Recently the technique has been used in the ankle. We present a series of patients treated with MACI for osteochondral defects of the ankle, and assess the functional and clinical results.
MATERIALS AND METHODS: From August 2003 to February 2006, 20 patients underwent MACI grafting for osteochondral defects in the ankle. Age ranged from 19 to 61 (mean, 36) years. Mean followup was 21.1 months. Clinical and functional evaluations were conducted using the AOFAS scoring system.
RESULTS: The mean size was 233 mm(2). There was a significant improvement in mean AOFAS score from 60 (range, 25 to 87) to 87 (range, 41 to 100) (p < 0.0001). Overall improvement in pain scores was also significant (p < 0.0001). All osteotomies healed. Four patients required hardware removal and two underwent arthroscopic debridement for anterior impingement. There were two failures which are awaiting subsequent procedures.
CONCLUSION: We believe MACI is a reliable treatment method for talar osteochondral defects. The method usually requires an intra-articular osteotomy, although this proved to be a reasonably simple aspect of the procedure for the treatment of cartilage defects of the talus.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19755063     DOI: 10.3113/FAI.2009.0810

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  23 in total

1.  Arthroscopic autologous chondrocyte implantation in the ankle joint.

Authors:  Sandro Giannini; Roberto Buda; Alberto Ruffilli; Marco Cavallo; Gherardo Pagliazzi; Maria Chiara Bulzamini; Giovanna Desando; Deianira Luciani; Francesca Vannini
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2013-09-01       Impact factor: 4.342

Review 2.  Osteochondral lesions of the talus in the athlete: up to date review.

Authors:  Yoshiharu Shimozono; Youichi Yasui; Andrew W Ross; John G Kennedy
Journal:  Curr Rev Musculoskelet Med       Date:  2017-03

3.  Autologous chondrocyte implantation for the treatment of chondral and osteochondral defects of the talus: a meta-analysis of available evidence.

Authors:  Philipp Niemeyer; Gian Salzmann; Hagen Schmal; Hermann Mayr; Norbert P Südkamp
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2011-10-30       Impact factor: 4.342

4.  [Malleolar osteotomy--osteotomy as approach].

Authors:  A Barg; G Pagenstert; A Leumann; V Valderrabano
Journal:  Orthopade       Date:  2013-05       Impact factor: 1.087

Review 5.  Operative Treatment for Osteochondral Lesions of the Talus: Biologics and Scaffold-Based Therapy.

Authors:  Youichi Yasui; Adi Wollstein; Christopher D Murawski; John G Kennedy
Journal:  Cartilage       Date:  2016-05-09       Impact factor: 4.634

6.  Treatment of deep articular talus lesions by matrix associated autologous chondrocyte implantation--results at five years.

Authors:  Sven Anders; Juergen Goetz; Thomas Schubert; Joachim Grifka; Jens Schaumburger
Journal:  Int Orthop       Date:  2012-08-12       Impact factor: 3.075

7.  Efficacy and safety of autologous chondrocyte implantation for osteochondral defects of the talus: a systematic review and meta-analysis.

Authors:  Mu Hu; Xingchen Li; Xiangyang Xu
Journal:  Arch Orthop Trauma Surg       Date:  2021-06-14       Impact factor: 3.067

8.  Clinical outcome and T2 assessment following autologous matrix-induced chondrogenesis in osteochondral lesions of the talus.

Authors:  Eva Johanna Kubosch; Benjamin Erdle; Kaywan Izadpanah; David Kubosch; Markus Uhl; Norbert P Südkamp; Philipp Niemeyer
Journal:  Int Orthop       Date:  2015-09-08       Impact factor: 3.075

9.  High-Density Autologous Chondrocyte Implantation as Treatment for Ankle Osteochondral Defects.

Authors:  Juan Manuel López-Alcorocho; Isabel Guillén-Vicente; Elena Rodríguez-Iñigo; Ramón Navarro; Rosa Caballero-Santos; Marta Guillén-Vicente; Mercedes Casqueiro; Tomás F Fernández-Jaén; Fernando Sanz; Santiago Arauz; Steve Abelow; Pedro Guillén-García
Journal:  Cartilage       Date:  2019-03-17       Impact factor: 4.634

10.  The use of fibrin matrix-mixed gel-type autologous chondrocyte implantation in the treatment for osteochondral lesions of the talus.

Authors:  Kyung Tai Lee; Jin Su Kim; Ki Won Young; Young Koo Lee; Young Uk Park; Yong Hoon Kim; Hun Ki Cho
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2012-06-30       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.